Image source: Getty Images.
When you hear the term “value dividend stock,” biotech isn’t a sector that immediately comes to mind. Investors in that growthiest of growth industries often discard their P/E ratios and “buy at” prices and instead take moonshots, with the hope that one of their investments will hit the jackpot. Yet among the mature biotechs, occasionally a discerning investor can buy a stock that’s seriously on sale.